Financhill
Back

Innovate Vs. Regeneron Pharmaceuticals Industry Stock Comparison

Sell
24

VATE
Innovate

Last Price:
$5.36
Seasonality Move:
-11.75%
Sell
42

REGN
Regeneron Pharmaceuticals

Last Price:
$520.94
Seasonality Move:
10.58%
Sell
24
Innovate (VATE) is a Sell

Is Innovate a Buy, Sell or Hold?

  • The current Innovate [VATE] share price is $5.36. The Score for VATE is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • VATE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $521.00. The Score for REGN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VATE Stock Price Chart

What is Innovate's stock price today?

  • The Innovate share price today is $5.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VATE is experiencing buying pressure, which is a positive indicator for future bullish movement.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $521.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight selling pressure.

VATE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 44.12 Sell
Chaikin Money Flow: 31571 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.16 - 6.22) Sell
Bollinger Bands (100): (5.21 - 9.83) Sell

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -10.92 Sell
Relative Strength Index (14 RSI): 45.56 Sell
Chaikin Money Flow: -767855 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (489.58 - 564.66) Sell
Bollinger Bands (100): (537.39 - 674.91) Sell

VATE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.28 Buy
20-day SMA: 5.46 Sell
50-day SMA: 5.97 Sell
200-day SMA: 6.46 Sell
8-day EMA: 5.31 Buy
20-day EMA: 5.51 Sell
50-day EMA: 6.03 Sell
200-day EMA: 6.85 Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 516.08 Buy
20-day SMA: 509.62 Buy
50-day SMA: 554.33 Sell
200-day SMA: 733.32 Sell
8-day EMA: 518.72 Buy
20-day EMA: 524.97 Sell
50-day EMA: 553.77 Sell
200-day EMA: 696.93 Sell

Innovate Earnings Growth & VATE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.42 per share, a decrease next quarter of $0.05 per share, a decrease this year of $9.47 per share, and an increase next year of $4.72 per share.

Innovate Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):